Breast cancer prognostic markers in the post-genomic era

Breast Cancer Research and Treatment

Volumn 125, Issue 3, 2011, Pages 647-650

  Pusztai, Lajos ^a   Iwamoto, Takayuki ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; MESSENGER RNA;

BREAST CANCER; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; NOTE; PRIORITY JOURNAL; PROGNOSIS; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECURRENCE; RNA, MESSENGER; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79151483151     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0932-x     Document Type: Note

References (12)

1. L Pusztai B Leyland-Jones 2008 Promises and caveats of in-silico biomarker discovery Br J Cancer 99 385 386 1:CAS:528:DC%2BD1cXptFSntL4%3D 10.1038/sj.bjc.6604495 18665186
2. Gyorffy B, Lanczky A, Eklund AC et al (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1809 patients. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0674-9
3. Greenbaum D, Colangelo C, Williams K et al. (2003) Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4: 117-117.8
4. P Lu C Vogel R Wang, et al. 2007 Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation Nat Biotechnol 25 117 124 1:CAS:528:DC%2BD2sXis1Grsw%3D%3D 10.1038/nbt1270 17187058 (Pubitemid 46087910)
5. M Schmidt D Hasenclever M Schaeffer, et al. 2008 Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer Clin Cancer Res 14 5849 5855 1:CAS:528:DC%2BD1cXhtFaitrjM 10.1158/1078-0432.CCR-08-0669 18794096
6. F Andre C Hatzis K Anderson, et al. 2007 Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer Clin Cancer Res 13 2061 2067 1:CAS:528:DC%2BD2sXjs12rtrY%3D 10.1158/1078-0432.CCR-06-2078 17404087 (Pubitemid 46649873)
7. T Iwamoto G Bianchini C Coutant, et al. 2009 Different biological processes are associated with prognosis and chemotherapy sensitivity in the different molecular subtypes of breast cancer Cancer Res 69 Suppl 864s 10.1158/0008-5472.SABCS-09-6124 (Abs 6124)
8. M Schmidt ME Scheulie C Dittrich, et al. 2010 An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer Ann Oncol 21 275 282 1:STN:280:DC%2BC3c%2Fls1entA%3D%3D 10.1093/annonc/mdp314 19633042
9. RM Simon S Paik DF Hayes 2009 Use of archived specimens in evaluation of prognostic and predictive biomarkers J Natl Cancer Inst 101 1446 1452 10.1093/jnci/djp335 19815849
10. C Sotiriou L Pusztai 2009 Gene-expression signatures in breast cancer N Engl J Med 360 790 800 1:CAS:528:DC%2BD1MXitFWqs70%3D 10.1056/NEJMra0801289 19228622
11. P Wirapati C Sotiriou S Kunkel Farmer, et al. 2008 Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures Breast Cancer Res 10 R65 10.1186/bcr2124 18662380
12. JX Yu AM Sieuwerts Y Zhang, et al. 2007 Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer BMC Genomics 7 182 10.1186/1471-2407-7-182 (Pubitemid 350111685)